Current Pharmacogenomics and Personalized Medicine
Title:Modulating Blood-Brain Barrier Permeability and Treatment-Resistant Psychiatric Illness: Is Pituitary Neuroimaging a New Frontier?
Volume: 10 Issue: 3
Author(s): Christopher Reist, Jogeshwar Mukherjee and Joseph C. Wu
Affiliation:
Keywords: Antipsychotic, Blood-brain-barrier, Dopamine receptor, Neuroimaging, P-glycoprotein, Pituitary.
Export Options
About this article
Cite this article as:
Reist Christopher, Mukherjee Jogeshwar and C. Wu Joseph, Modulating Blood-Brain Barrier Permeability and Treatment-Resistant Psychiatric Illness: Is Pituitary Neuroimaging a New Frontier?, Current Pharmacogenomics and Personalized Medicine 2012; 10 (3) . https://dx.doi.org/10.2174/187569212802509979
DOI https://dx.doi.org/10.2174/187569212802509979 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial (Thematic Selection: 'Glutamatergic-based Rapid Acting Antidepressants: The Link to Synaptic Plasticity')
Current Neuropharmacology Neurological Involvement in Rheumatoid Arthritis
Current Immunology Reviews (Discontinued) Inhibitors of Nitric Oxide Synthase: What's up and What's Next?
Current Enzyme Inhibition Neurodegeneration and Neuroinflammation in Diabetic Retinopathy: Potential Approaches to Delay Neuronal Loss
Current Neuropharmacology Boom and Bust for Homocysteine?
Central Nervous System Agents in Medicinal Chemistry Natural Resins and Bioactive Natural Products thereof as Potential Anitimicrobial Agents
Current Pharmaceutical Design Women Tipping the Scale During Pregnancy: A Special Population for Obesity Interventions,Treatments and Clinical Trials
Current Pharmaceutical Design Cholinesterase Inhibitors Modulate Autonomic Function in Patients with Alzheimer´s Disease and Mixed Dementia
Current Alzheimer Research Crystal Structures of Acridines Complexed with Nucleic Acids
Medicinal Chemistry Reviews - Online (Discontinued) Antidotal Effects of Curcumin Against Agents-Induced Cardiovascular Toxicity
Cardiovascular & Hematological Disorders-Drug Targets Mitochondrial Common Deletion Level in Blood: New Insight Into the Effects of Age and Body Mass Index
Current Aging Science Examination of Hippocampal Differences Between Alzheimer Disease, Amnestic Mild Cognitive Impairment and Normal Aging: Diffusion Kurtosis
Current Alzheimer Research LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson’s Disease, Where Do We Stand?
Current Neuropharmacology Pharmacological Treatments of Opiate Dependence
Current Pharmaceutical Design Mitochondria as a Target for Exercise-Induced Cardioprotection
Current Drug Targets Lipoxygenases - A Challenging Problem in Enzyme Inhibition and Drug Development
Current Enzyme Inhibition There is no Failure, Only Discovery—the Year Ahead for CARving New Paths
Current Alzheimer Research Gene Therapy for Parkinsons Disease: Progress and Challenges
Current Gene Therapy Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets Agomelatine in the Treatment of Major Depressive Disorder: An Assessment of Benefits and Risks
Current Neuropharmacology